Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Stelara
Active Ingredient: Ustekinumab 45mg
Dosage Form: Solution for injection
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturers: Cilag AG, Schaffhausen, Switzerland
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America
   
Product: Stelara
Active Ingredient: Ustekinumab 90mg
Dosage Form: Solution for injection
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturers: Cilag AG, Schaffhausen, Switzerland
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America
   
Product: Stelara
Active Ingredient: Ustekinumab 130mg
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Cilag AG, Schaffhausen, Switzerland


Dated this 6th day of December 2019.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).